Treatment of Idiopathic Pulmonary Fibrosis.

Division

South Atlantic

Hospital

Grand Strand Medical Center

Document Type

Manuscript

Publication Date

5-1-2021

Keywords

future management, ipf, literature review of disease, progressive interstitial lung disease, pulmonary disease

Disciplines

Internal Medicine | Respiratory Tract Diseases

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown cause, occurring in adults and limited to the lungs. In the past, treatment was aimed at minimizing inflammation and slowing the progression of inflammation to fibrosis. However, the underlying lesion in IPF may be more fibrotic than inflammatory, explaining why few patients respond to anti-inflammatory therapies and the prognosis remains poor. In this review of literature, we will be focusing on main lines of treatment including current medications, supportive care, lung transplantation evaluation, and potential future strategies of treatment.

Publisher or Conference

Cureus

Link to Full Text

Share

COinS